Summary
Elevance Health, Inc. (ELV) filed an 8-K on October 17, 2023, to report its financial results for the quarter ended September 30, 2023. The primary purpose of this filing is to provide investors with the company's latest financial performance through a furnished press release (Exhibit 99.1). While the 8-K itself doesn't contain the detailed results, it formally announces the availability of this information, allowing investors to access the press release for a comprehensive overview of revenue, earnings, and other key financial metrics for the specified period. This report serves as a notification to the market that Elevance Health has released its quarterly financial update. Investors and analysts should refer to the press release, Exhibit 99.1, for specific figures and management commentary on operational performance, growth drivers, and the company's outlook. The filing also includes standard forward-looking statement disclaimers, advising caution regarding future projections due to inherent business risks and uncertainties in the healthcare industry.
Key Highlights
- 1Elevance Health filed an 8-K on October 17, 2023, to report Q3 2023 financial results.
- 2The filing officially disseminates the company's financial performance for the quarter ended September 30, 2023.
- 3Key financial details and operational updates are provided via an attached press release (Exhibit 99.1).
- 4Investors are directed to the press release for comprehensive Q3 2023 financial results and commentary.
- 5The report includes standard forward-looking statement disclaimers regarding potential risks and uncertainties.
- 6Information furnished under Item 2.02 is not considered 'filed' for Section 18 purposes, limiting liability.